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العكرب يعدل من وسائط االلتهاب وحيسن الرتكيب النسيجي لذكور اجلرذان 
املصابة بالتهاب البنكرياس احلاد احملدث بواسطة األرجينني
حممد طه احلريري، ثروت جمال الدين، طارق ها�شم، �شاهان�س �شاثوث، عبد اهلل ال�شويد
abstract: Objectives: This study aimed to determine the effects of propolis on immune mediators and tissue 
histopathology in rats with L-arginine-induced acute pancreatitis (AP). Methods: This study was conducted at 
Imam Abdulrahman Bin Faisal University, Dammam, Saudia Arabia between September and November 2017. A 
total of 24 male albino Wistar rats were divided into three equal groups. Group one was the negative control, 
group two was the positive control (L-arginine-induced AP) and group three received treatment (L-arginine-
induced AP and propolis). The rats in group three were treated with 100 mg/kg propolis for seven days after AP 
induction. Pancreatic tissue was evaluated histologically and levels of interleukin (IL)-6, IL-22 and IL-1β and 
tumour necrosis factor-alpha (TNF-α) were measured. Results: Propolis reduced the quanitity of proinflammatory 
molecules (TNF-α, IL-1β and IL-6) in group three compared to group two, significantly increased the overall anti-
inflammatory effect of IL-22 (P <0.005) and reduced interstitial inflammation and neutrophil cell infiltration of 
the pancreatic tissues. Conclusion: Propolis may exert a therapeutic effect in AP. Further studies are required to 
demonstrate the mechanisms of propolis in AP.
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والتغريات  الدم،  البيوكيميائية يف  والوا�شمات  املناعة  و�شائط  العكرب على  فعالية  الدرا�شة حتديد  الهدف من هذه  الهدف: كان  امللخ�ص: 
الن�شيجية يف اجلرذان امل�شابة بالتهاب البنكريا�س احلاد. الطريقة: اأجريت هذه الدرا�شة يف جامعة االإمام عبد الرحمن بن في�شل، الدمام، 
اململكة العربية ال�شعودية بني �شهري �شبتمرب ونوفمرب 2017. مت تق�شيم 42 من ذكور اجلرذان املهق اإىل 3 جمموعات مت�شاوية. املجموعة 
االأوىل: ال�شابطة ال�شلبية؛ املجموعة الثانية: ال�شابطة االإيجابية وهي امل�شابة بالتهاب البنكريا�س احلاد املحدث بوا�شطة االرجنني؛ املجموعة 
الثالثة: جمموعة م�شابة بالتهاب البنكريا�س و مت معاجلتها بالعكرب )100 جمم/كجم/ملدة 7 اأيام(. يف نهاية فرتة البحث متت درا�شة اأن�شجة 
البنكريا�س ومت قيا�س م�شتويات االإنرتلوكني )6، 22، 1ب( وعامل نخر الورم األفا. النتائج: اأظهرت النتائج اأن العكرب قد قلل من كمية جزيئات 
ما قبل االلتهابات وهي االإنرتلوكني )6، 1ب(و من م�شتوى عامل نخر الورم األفا مقارنة باملجموعة الثانية، وزاد ب�شكل كبري من التاأثري امل�شاد 
لاللتهابات بوا�شطة اإنرتلوكني 22 عند داللة اإح�شائية تعادل )P >0.005( اإ�شافة اإىل اأن العكرب قد قلل ب�شكل ملحوظ من االلتهاب الن�شيجي 
للبنكريا�س. اخلال�صة: اأظهرت الدرا�شة اأن للعكرب تاأثريا عالجيا يف التهاب البنكريا�س احلاد، االأمر الذي يفتح االأبواب الإجراء العديد من االأبحاث 
يف هذا اخل�شو�س الإثبات اآليات عمل العكرب يف عالج مثل هذه احلاالت.
الكلمات املفتاحية: العكرب؛ اأرجينني؛ التهاب البنكريا�س؛ اإنرتلوكني؛ �شايتوكني؛ اجلرذان؛ العربية ال�شعودية.
Propolis Modulates Inflammatory Mediators and 
Improves Histopathology in Male Rats with 
L-arginine-induced Acute Pancreatitis
*Mohammed T. Al-Hariri,1 Tharwat G. Eldin,1 Tarek Hashim,2 Shahanas Chathoth,3 Abdullah Alswied1
Sultan Qaboos University Med J, May 2019, Vol. 19, Iss. 2, pp. e103–107, Epub. 8 Sep 19
Submitted 2 Oct 18
Revision Req. 3 Dec 18; Revision Recd. 26 Dec 18
Accepted 17 Jan 19
Advances in Knowledge
- The present study identifies the anti-pancreatitis effect of propolis. 
- The anti-pancreatitis effect takes potential inflammatory and proinflammatory pathways.
Application to patient care 
- Propolis minimised inflammatory response and pancreatic tissue damage.
- Propolis should be considered an effective and promising natural compound for managing acute pancreatitis.
Pancreatitis is a major gastrointestinal problem worldwide.1 Despite the development of new therapeutic and diagnostic approaches, 
the clinical course of acute pancreatitis (AP) is assoc- 
iated with significant morbidity and a high mortality 
rate.2,3
Experimental studies focused on the molecular 
pathway, including proinflammatory cytokines, are 
shedding light on the pathophysiologic mechanisms of AP. 
Increased levels of proinflammatory cytokines—such 
as interleukin (IL)-1, IL-6 and tumour necrosis factor-
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alpha (TNF-α)—aggravate AP by increasing vascular 
permeability.4-6
Propolis is a natural resinous compound collected 
by bees from the gum of various plants and converted 
through salivary secretions to beeswax. Propolis has attr- 
acted global attention for its wide range of pharmacol- 
ogical and biological properties, making propolis a poten- 
tially promising therapeutic agent.7 The efficacy of pro- 
polis depends mainly on the presence of flavonoids, 
primarily caffeic acid phenethyl ester (CAPE), which pro- 
vide an anti-inflammatory effect.8 Future studies should 
focus on standardising the therapeutic applications of 
propolis.9
Many studies have shown that the anti-inflamm- 
atory activity of propolis and/or its compounds inhibit 
the activation of cyclooxygenase (COX)-2 gene expression, 
suppress enzyme activities of COX-1 and COX-2 and 
inhibit the release of arachidonic acid from cell mem- 
branes.10,11
Galangin, a propolis-associated flavonoid, has been 
shown to decrease prostaglandin E2 release, inhibit 
lipoxygenase, COX and the expression of the inducible 
isoform of COX-2.12 This study aimed to determine the 
effects of propolis on immune mediators and tissue 
histopathology of rats with L-arginine-induced AP.
Methods
This study was conducted at Imam Abdulrahman Bin 
Faisal University, Dammam, Saudi Arabia from September 
to November 2017. A total of 24 male albino Wistar rats 
weighing 150–250 g were obtained from the university’s 
animal house for this study. All rats were maintained in 
a room at a constant temperature of 22 ± 1°C with 12 
hour light/dark cycles and had free access to standard 
laboratory food pellets and water.
The rats were equally divided into three groups. 
Group one was the untreated negative control group, 
group two consisted of the positive controls and group 
three was the experimental treatment group. Group 
two and three were injected with L-arginine to induce 
AP. Two intraperitoneal (IP) injections of L-arginine 
(Sigma-Aldrich Chemical, Merck KGaA, Darmstadt, 
Germany) at a dose of 250 mg/100 g of body weight 
(BW) prepared in isotonic saline (20% 0.15 M sodium 
chloride) were administered at a one-hour interval 
to induce AP.13 The rats in group three were treated 
orally with Brazilian green propolis alcohol extract 
(Uniflora Apicultores Associados Ltda, Olímpia, 
Brazil) 100 mg/kg of BW after two hours of L-arginine 
injection and daily for seven days.14 This dose has 
previously been shown to be anti-inflammatory.15 AP 
was diagnosed clinically as rats became sluggish and 
lethargic. The condition was most severe 72 hours 
after the L-arginine-injections and was confirmed by 
histopathological examination.16
The treatment regimens were stopped after seven 
days and 12 hours before the rats were anaesthetised 
with an IP injection of ketamine (50 mg/kg of BW; 
Alfasan International BV, Woerden, the Netherlands). 
Rats were euthanised and blood was collected from 
the abdominal aorta by means of a vacutainer.17 Anti-
inflammatory cytokines (IL-1β, IL-6, TNF-α and IL-
22) were assessed by enzyme-linked immunosorbent 
assay (ELISA). The IL-22 ELISA Kit (R&D Systems, 
Minneapolis, Minnesota, USA) and all other cytokine 
assays (Bio-Rad Laboratories Inc., Hercules, California, 
USA) were quantified in accordance with the manufact- 
urers’ guidelines and instructions.18,19
Pancreatic tissues were fixed in a 10% formal- 
dehyde solution for 48 hours, embedded in paraffin wax 
and sectioned. The sections were stained with haema- 
toxylin and eosin and evaluated under a light microscope 
to detect inflammatory manifestations, including oedema, 
leukocyte infiltration, parenchymal necrosis and haemo- 
rrhage in the pancreatic tissue. The general morphology 
and histological features were evaluated with a BX51 
photomicroscope (Olympus Corporation, Tokyo, Japan).20
Histopathologic scoring for AP included assess- 
ment of inflammatory cell infiltration, oedema and acinar 
degenerative changes. The inflammatory cells were 
counted in five high power field (HPF) × 400 images and 
the mean number of cells was calculated and rated. Fewer 
than 50 inflammatory cells/HPF was rated 1+ (mild), 
50–100 inflammatory cells/HPF was rated 2+ (moderate) 
and >100 inflammatory cells/HPF was rated 3+ (severe).
Statistical analysis was performed using Statistical 
Package of Social Science (SPSS), Version 21 (IBM Corp., 
Armonk, New York, USA). Data are presented as means ± 
standard error of the mean. One-way analysis of variance 
followed by Tukey’s multiple comparison post-hoc test 
was used to compare the means. Statistical significance 
was set at P <0.05.
All experiments were performed in accordance with 
the recommendations of the national guidelines for the 
care and handling of laboratory animals. The experimental 
protocol was approved by the Local Animal Ethics 
Committee (IRB 2015-01-185).
Results
Serum proinflammatory cytokines (IL-1β, IL-6 and 
TNF-α) and anti-inflammatory IL-22 in the three studied 
groups are shown in Table 1. Injecting two doses of 
L-arginine induced an increase in proinflammatory 
measurements and a decrease in the measured anti-
inflammatory cytokine concentration in group two. 
Moreover, pathohistological features of AP were present.
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The mean serum concentration of IL-1β was signif- 
icantly higher in group two than group one (P <0.005). 
Group two also had significantly higher TNF-α and IL-6 
than groups one and three (P <0.005 and P <0.001 each). 
The mean serum level of IL-22 for the propolis-treated 
group increased significantly compared to groups one 
and two (P <0.005 and P <0.001, respectively) [Table 1]. 
Group two was rated as 3+ and group three was rated 
at 2+.
While regular pancreas morphology was observed 
in the tissues of rats in group one [Figure 1], severe 
degrees of inflammatory cell infiltration, pancreatic 
tissue necrosis, haemorrhage and parenchymal degen- 
erative changes were observed in the tissues of rats in 
group two compared with the other groups (P <0.05) 
[Figure 2]. However, treatment with propolis in group 
three significantly decreased the degree of cellular 
infiltration, interstitial oedema, acinar cell necrosis and 
parenchymal degenerative changes compared to group 
two (P <0.05) [Figure 3].
Discussion
Previous studies have used experimental AP induced 
by L-arginine to study the effect of various therapeutic 
agents and the pathophysiologic mechanisms of the 
disease.21 The present study aimed to determine the 
effects of propolis on immune mediators and tissue 
histopathology in rats with AP. The effect of propolis 
was evidenced by a decrease in proinflammatory 
cytokines (TNF-α, IL-1β and IL-6) and a significant 
increase in the level of anti-inflammatory IL-22 to 
levels close to that of the negative controls.
Several studies have focused on the pathogenesis 
of AP.2,6 Overproduction of inflammatory mediators, 
including TNF-α, IL-1β, IL-6 and IL-8, was found to 
play an important role in the pathogenesis of AP.22 
Table 1: Serum analysis of proinflammatory (interleukin 
[IL]-1β, IL-6 and tumour necrosis factor-alpha) and anti- 
inflammatory (IL-22) cytokine in three rat groups 









36.39 ± 3.07 116.13 ± 4.28* 41.43 ± 4.01
IL-6 in 
pg/mL
39.02 ± 3.13 85.44 ± 3.39*‡ 45.21 ± 2.05
TNF-α in 
pg/mL
59.74 ± 1.40 96.91 ± 2.51*‡ 48.83 ± 1.51
IL-22 in 
pg/mL
0.19 ± 0.020 0.15 ± 0.023 0.30 ± 0.056*†
SEM = standard error of mean; IL = interleukin; TNF-α = tumour necr- 
osis factor-alpha.
*significantly different from group one (P <0.005);  †significantly different from 
group two (P <0.001);  ‡significantly different from group three (P <0.001).
 
Figure 1: Haematoxylin and eosin stain of pancreatic 
tissue from group one at x200 maginification showing 
normal, unremarkable pancreatic tissue in both exocrine 
(Exo) and endocrine parts (Islet). 
 
Figure 3: Haematoxylin and eosin stain of pancreatic 
tissue from group three at x400 maginification showing 
moderate interstitial inflammation and neutrophil cell 
infiltration of the pancreatic tissue (arrow).
 
Figure 2: Haematoxylin and eosin stain of pancreatic 
tissue from group two at x200 maginification showing 
significant severe interstitial inflammation, oedema with 
mixed mononuclear inflammatory cells (arrows) and neut- 
rophils. The pancreatic acini show moderate parenchymal 
degenerative changes (arrowheads).
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In the present study, propolis significantly reduced 
the total pathologic score and the extent of oedema, 
most likely due to the anti-inflammatory action of 
propolis and/or its active compounds.23 These results 
agree with those of previous studies from different AP 
models.24
Interestingly, an important and novel result of 
this study was the finding that propolis significantly 
increased levels of IL-22, which had not been tested 
in previous studies. The anti-inflammatory activities 
of propolis are still not fully understood. Pooran et al. 
suggested that propolis has an anti-inflammatory effect 
as it inhibits the release of histamine, prostaglandins 
and leukotrienes.22 Another study reported that the 
anti-inflammatory properties of propolis are due to 
CAPE.25 CAPE exerts its anti-inflammatory actions 
by suppressing the inflammatory enzyme activities 
of COX-1 and COX-2 and inhibiting the release of 
arachidonic acid from cell membranes.26
In the current study, there was non-significant 
minimal change in IL-22 levels between groups one and 
two. The increase of IL-22 in only group three could be 
via the signal transducer and activator of transcription 
(STAT) 3 signaling pathway in which exogenous 
recombinant IL-22 protected mice from L-arginine-
induced AP.27 The favourable effect of IL-22 is thought 
to depend on the extent of AP inflammation. In mild 
cases of induced AP, administration of exogenous 
IL-22 successfully aborted disease development.28 
Furthermore, over-expressed animal models of IL-22 
were resistant to AP development.29 Xue et al. was 
reported that the administration of the anti-IL-22 anti- 
body, to block the receptors, endogenously aggravated 
pancreatic injury which supports the essential role 
of IL-22.30 Collectively, these findings strongly suggest 
that IL-22 plays a vital role in AP prevention. Further- 
more, IL-22 may mediate a protective effect against 
L-arginine-induced AP via activation of the STAT3 
signaling pathway, which can suppress apoptosis by 
inducing downstream genes, including Bcl-xL and Bcl-2.31
While some studies have discussed several promising 
mechanisms, the proposed therapeutic effect of propolis 
needs further investigation to better characterise the 
mechanism by which it exerts the observed therapeutic 
effect.26,32 The push-and-pull between the anti-inflamm- 
atory and proinflammatory cytokines are believed to 
determine the outcome of AP.33,34 Immune-modifying 
therapeutic approaches have been used for many 
inflammatory conditions with the aim of promoting 
the release of the anti-inflammatory cytokines and/or 
hindering the release of the inflammatory cytokines. 
Recently, Lattanzi et al. provided evidence for the 
potential contributions of the inflammatory reaction 
and/or inflammatory-induced oxidative stress in the 
aetiopathogenesis of several complicated disorders 
such as acute stroke and degenerative and secondary 
dementia.35 The anti-inflammatory properties of propolis 
could suggest novel pathophysiology-oriented treat- 
ment options in the management of various medical 
conditions where inflammation plays a pivotal role in 
the development and progression of tissue damage.36
Conclusion
Propolis attenuated the severity of inflammation of 
the pancreatic tissues of rats with L-arginine-induced 
AP. Therefore, propolis could be investigated as a 
potential treatment for many inflammatory conditions 
in humans.
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